» Articles » PMID: 29727071

Risk of Type 2 Diabetes in Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder: A Nationwide Longitudinal Study

Overview
Specialty Psychiatry
Date 2018 May 5
PMID 29727071
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Studies have suggested there is an association between attention-deficit/hyperactivity disorder (ADHD) and type 2 diabetes mellitus (DM)-related risk factors, such as obesity, hypertension, and dyslipidemia. However, the association between ADHD and type 2 DM remains unknown.

Methods: Using the Taiwan National Health Insurance Research Database, we enrolled 35,949 adolescents and young adults with ADHD (ICD-9-CM code: 314) and 71,898 (1:2) age- and sex-matched controls from 2002 through 2009 and followed up with them until the end of 2011. Participants who developed type 2 DM during the follow-up period were identified.

Results: Adolescents (hazard ratio [HR] = 2.83; 95% CI, 1.96-4.09) and young adults (HR = 3.28; 95% CI, 1.41-7.63) with ADHD had a higher risk of developing type 2 DM than did the controls after adjustment for demographic characteristics, use of ADHD medications and atypical antipsychotics, and medical comorbidities. Individuals with ADHD had a shorter mean ± SD duration between enrollment and onset of type 2 DM (3.17 ± 2.33 vs 4.08 ± 2.11 years, P = .004) during the follow-up compared with the controls. Sensitivity analyses after excluding first-year (HR = 2.36; 95% CI, 1.65-3.38) and first-3-year (HR = 1.92; 95% CI, 1.19-3.09) observation periods were consistent. Long-term use of atypical antipsychotics was associated with a higher likelihood of subsequent type 2 DM (HR = 2.82, 95% CI, 1.74-4.58).

Discussion: Adolescents and young adults with ADHD were more likely than non-ADHD controls to develop type 2 DM in later life. In addition, those with ADHD taking atypical antipsychotics exhibited a higher risk. Although correlation does not equal causation, our findings merit further study about the relationship between ADHD and type 2 DM.

Citing Articles

Addiction to Smartphone Use in Smokers Diagnosed with Type 2 Diabetes in Jordan: Are Their Medications Involved?.

Gammoh O, Alsous M, Al-Ameri M, Al-Jabari S, Sbitan L, Alsheyyab J Healthcare (Basel). 2025; 12(24.

PMID: 39765989 PMC: 11675955. DOI: 10.3390/healthcare12242559.


Mediating pathways between attention deficit hyperactivity disorder and type 2 diabetes mellitus: evidence from a two-step and multivariable Mendelian randomization study.

Zhang J, Chen Z, Triatin R, Snieder H, Thio C, Hartman C Epidemiol Psychiatr Sci. 2024; 33:e54.

PMID: 39465621 PMC: 11561680. DOI: 10.1017/S2045796024000593.


The adult ADHD assessment quality assurance standard.

Adamou M, Arif M, Asherson P, Cubbin S, Leaver L, Sedgwick-Muller J Front Psychiatry. 2024; 15:1380410.

PMID: 39156609 PMC: 11327143. DOI: 10.3389/fpsyt.2024.1380410.


Wider health needs in attention deficit hyperactivity disorder from lived and professional experience: a qualitative framework analysis.

Ward J, McBride A, Gudka R, Becker K, Newlove-Delgado T, Price A BMJ Open. 2024; 14(8):e083539.

PMID: 39153774 PMC: 11331868. DOI: 10.1136/bmjopen-2023-083539.


Patient, supporter and primary healthcare professional perspectives on health risks in over 16s with attention deficit hyperactivity disorder (ADHD) in England: a national survey study.

Ward J, Becker K, Smith J, Price A, Newlove-Delgado T BMC Health Serv Res. 2024; 24(1):751.

PMID: 38898441 PMC: 11188530. DOI: 10.1186/s12913-024-11188-5.